Ivelisse Sanchez, Ph.D.

Ivelisse Sanchez, Ph.D. has a diverse and extensive work experience in the field of neurosciences and biomedical research. Ivelisse started their career as a Research Fellow in Molecular Neuroscience at McLean Hospital in 1993. Later, they worked as an Instructor and Research Fellow in the Department of Cell Biology at Harvard Medical School, where their research focused on cell death pathways in neurodegenerative diseases. Ivelisse then joined Boston University School of Medicine as an Assistant Professor and Head of the Systems Molecular Signaling and Chemical Biology Lab, where they studied the role and regulation of polyglutamine proteins in the brain.

In 2009, Dr. Sanchez moved to the Health Sciences Research Institute Germans Trias i Pujol Research Institute (IGTP) as a Principal Investigator in Neurosciences. Here, they designed and implemented biomedical research lines in the area of translational signaling on metabolic regulation and disease, particularly in neurodegenerative diseases. Ivelisse also trained and mentored researchers at various levels and directed master and doctoral theses. Additionally, they served as the Director of the Functional Biology and Experimental Therapeutics lab/Neurogenetics Unit at IGTP.

In 2018, Dr. Sanchez became the co-Founder and Chief Scientific Officer of Biointaxis, an academic spin-off focused on the development of a gene therapy for rare neurodegenerative disorders. In this role, they shaped and drove the strategic initiatives of the start-up, managed research personnel and intellectual property, handled scientific communications and regulatory compliance, and implemented the scientific strategic plan.

Dr. Sanchez's work experience also includes their current role as Editor-In-Chief of the Journal of Molecular Histology, which they took on in 2020. In this position, they contribute to the strategic plan for the journal's professional reach and impact, makes final decisions on the selection of research reports to be published, and manages the content and quality of the journal with the help of Associate editors and the editorial board of experts. Under their leadership, the journal has witnessed significant growth, including a 44% increase in citable items and a 13% increase in Impact Factor within one year.

Overall, Dr. Ivelisse Sanchez has made significant contributions to the field of neurosciences through their extensive research, leadership, and mentoring roles in prestigious academic and research institutions.

Ivelisse Sanchez, Ph.D., has a solid education background in the field of developmental neurobiology and neuroscience. Between 1993 and 1998, they attended Harvard Medical School as a Postdoctoral Fellow in the Department of Psychiatry, where they focused on developmental neurobiology and neuroscience.

Additionally, they obtained a Master of Arts (M.A.) and a Doctor of Philosophy (Ph.D.) degree from The Graduate Center, City University of New York. Their field of study during this time was in cell, molecular, and developmental biology. The exact years of their M.A. and Ph.D. are not provided.

In terms of additional certifications, Ivelisse Sanchez received accreditation in research at the Associate Professor level (AQU-Profesor Agregat) from AQU Catalunya (Agency for the quality in University System) in 2013. However, the specific month of obtaining this certification is not mentioned.